NFKB1 and acute myeloid leukemia: NF-κB is a transcription factor that is constitutively activated in primitive AML cells, and its expression can be reduced by HHT in multiple myeloma cells, while ATO was shown to suppress NF-κB activation in mantle cell lymphoma cells [13–15].